SCHEMBL15030671

SCHEMBL15030671

c1ccc(-c2ccc(N3c4ccc(-c5ccccc5)cc4C4(c5ccccc5Oc5ccccc54)c4cc(-c5ccc6c(c5)C5(c7ccccc7Oc7ccccc75)c5ccc(-c7ccccc7)cc5N6c5cccc(-c6ccccc6)c5)ccc43)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.36
MGLL Q99685 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HSP90AA1 P07900 1/20 0.36
PKM P14618 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
BACE1 P56817 1/20 0.31
DHFR P00374 1/20 0.31
ADAMTS5 Q9UNA0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15030883 0.99 FAAH (0.37) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL16186675 0.93 ALDH1A1 (0.39) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL15030759 0.93 ALDH1A1 (0.39) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL15030645 0.93 ALDH1A1 (0.39) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL15030757 0.93 ALDH1A1 (0.41) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL15030755 0.92 ALDH1A1 (0.38) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL15030775 0.92 FAAH (0.33) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL16186674 0.90 FAAH (0.36) FAAHMGLLALDH1A1HSP90AA1PKM
SCHEMBL15030708 0.90 FAAH (0.34) FAAHMGLLBACE1ADAMTS5
SCHEMBL16186704 0.90 FAAH (0.34) FAAHMGLLALDH1A1HSP90AA1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2019-05-28 US disclosed
EP-2780325-B1 SPIRO-DIHYDROACRIDINE DERIVATIVES AND THEIR USE AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-02-03 EP disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 US disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 US disclosed
WO-2013083216-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2013-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices SORD, ALDH1A1, SDHA FAAH 4733/4885MGLL 4751/4885ALDH1A1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.